Clonmel, 10th July 2025 – Clonmel Healthcare, the number one generic supplier of medicines by value and volume in the Irish market*, delivered over 200 voluntary health screenings to attendees at the Clonmel Show on Sunday 6th July. In celebration of the company’s 55th year in business, a dedicated team of nurses provided vital basic health checks.
A steady stream of visitors to the stand throughout the day took advantage of the nurse-led checks including blood pressure, pulse, and oxygen levels. This positive response highlights a clear community appetite for accessible health information and services.
The initiative comes at a critical time, as new research released by Clonmel Healthcare revealed a concerning trend: almost one third of Irish people (31%) do not engage in any preventative health checks. The comprehensive study**, part of a global survey across 22 countries, sheds light on the barriers preventing individuals from taking proactive steps for their health. Reasons cited by the 31% of Irish respondents include a lack of awareness about recommended check-ups (28%), perceived cost (21%), limited access/availability (17%), and, notably, avoiding check-ups for fear of a bad diagnosis (15%).
“It was great to see a strong turnout at the Clonmel Show and we were delighted to provide 200 free health checks to our local community on the day,” commented Donagh O’Leary, Managing Director, Clonmel Healthcare. “Our recent research underscores the vital importance of initiatives like this. It is clear there’s a significant gap in preventative health engagement across Ireland, driven by factors like awareness and even fear. We are committed to addressing these barriers through education and community support.
Our presence at the Clonmel Show was more than just a celebration of our 55 years, it was a tangible step towards demystifying health checks and making them accessible.”
Clonmel Healthcare has a long and proud history of serving the Irish community, offering a wide range of over-the-counter medicines, prescription pharmaceuticals, and innovative speciality medication solutions in areas such as Parkinsons Disease and Biosimilars.
For further information, visit: www.clonmelhealthcare.ie
Read the latest News at IPN HERE
Read IPN July HERE
